Published in Gene Therapy Weekly, October 16th, 1995
The award, which provides for approximately $407,000 of funding in the first year, was awarded by the U.S. National Cancer Institute (NCI), in the form of a Cooperative Agreement award.
Memorial Sloan Kettering Cancer Center has joined Xenova and PharmaGenics, collaborators since 1994, to form a National Cooperative Natural Products Drug Discovery Group. The group will utilize the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.